Cancer Drug Promising for Alzheimer's Disease
9 days ago - By Medscape
In a small phase 2 trial, GM-CSF/sargramostim provided measurable disease-modifying and memory-enhancing benefits in patients with mild-to-moderate Alzheimer's disease.
Medscape Medical News
Read more ...
Search by Tags
Drugs Cancer Alzheimer Psychiatry News